Retaglutide is a innovative GLP-1 receptor agonist currently under study for the management of type 2 diabetes. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://blanchenefe961440.jts-blog.com/37729989/retaglutide-a-promising-glp-1-receptor-agonist